Document is current

Article History

Received: 30 September 2024

Accepted: 22 December 2024

First Online: 30 December 2024

Declarations

:

: The trial received ethics approval from the University of New South Wales Human Research Ethics Committee (HC200970).

: Not applicable.

: JHYW is a member of the Editorial Board of International Journal of Behavioral Nutrition and Physical Activity. JHYW was not involved in the journal’s peer review process of, or decisions related to, this manuscript. In the last 3 years, JHYW has received grant support from New South Wales (NSW) Health, Ian Potter Foundation, Hort Innovation, and Future Food System Cooperative Research Centre, as well as travel support by AusVeg, all outside of the present work. In the last 3 years, MDH has received travel support from the World Heart Federation. MDH has planned patents for combination therapy for the treatment of heart failure. AJC and CNM were academic partners on a healthy supermarket intervention trial that includes Australian local government and supermarket retail (IGA) collaborators, with funding from the Australian National Health and Medical Research Council (NHMRC), the Victorian Health Promotion Foundation (VicHealth) and Deakin University. The George Institute for Global Health has a patent, license, and has received investment funding with intent to commercialize fixed-dose combination therapy for hypertension through its social enterprise business, George Medicines. The George Institute has also previously received funding from Australian supermarket retailers to independently assess and provide advice on improving the healthiness of private label (home brand) product ranges. BN is supported by an Australian NHMRC fellowship. AES is supported by a NHMRC Investigator Grant (APP2017504), has received funding from the MRFF and NSW Health, and has also received speaker honoraria or sat on Advisory Boards for Servier, Medtronic, Sanofi, AstraZeneca, Omron, Aktiia, Skylabs, and Abbott. CA has received research funding from NHMRC, MRFF and NSW Health and has also received honoraria or sat on Advisory Boards for Novo Nordisk, Amgen and Astra Zeneca.